Weighted Average Number of Shares Outstanding, Basic of Aptevo Therapeutics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aptevo Therapeutics Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Aptevo Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 4,049,046, a 28306% increase year-over-year.
  • Aptevo Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 276,137.
  • Aptevo Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 7,515.
  • Aptevo Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 5,100,310, a 8.8% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,049,046 +4,034,792 +28306% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 738,149 -4,017,851 -84% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 1,458,458 +1,439,898 +7758% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 276,137 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 14,254 -271,632 -95% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 4,756,000 +4,608,679 +3128% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 18,560 -141,037 -88% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 285,886 -4,804,706 -94% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 147,321 -4,876,000 -97% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 159,597 -4,777,859 -97% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 5,100,310 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 5,090,592 +198,711 +4.1% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 5,023,321 +486,804 +11% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 4,937,456 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 4,891,881 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 4,536,517 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q3 2018 22,672,721 +1,287,340 +6% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 22,588,334 +1,322,735 +6.2% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 22,025,268 +1,268,157 +6.1% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 21,385,381 +1,149,394 +5.7% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 21,265,599 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 20,757,111 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q3 2016 20,235,987 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3

Aptevo Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 276,137 +268,622 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
2023 7,515* -5,092,795 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
2022 5,100,310 +412,358 +8.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 4,687,952 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.